Johnson & Johnson’s Vaccine Offers Strong Protection but Fuels Concern About Variants
Coronavirus,Coronavirus Vaccine
From the Left
AllSides Media Bias Rating: Lean Left
Johnson & Johnson, the only major drug maker developing a single-dose vaccine for Covid, announced on Friday that its shot provided strong protection against Covid-19, potentially offering another powerful tool in a desperate race against a worldwide rise in virus mutations.
But the results came with a significant cautionary note: The vaccine’s efficacy rate dropped from 72 percent in the United States to 57 percent in South Africa, where a highly contagious variant is driving most cases.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
Related Coverage
AllSides Picks
Red Blue Translator
Anti-vaxxer
Headline Roundup
Fewer International Students Enrolled in US Colleges for Second Consecutive Year
November 16th, 2026
Headline Roundup
SCOTUS Denies Trump's Appeal to Cut DEI Funding to University of California
November 16th, 2026
Recommended Reading
When Democrats Have To Decide
Dan Schnur
November 16th, 2026